VaramirStart free · no cardSign in
ARVN as of Oct 31 · 15:00 ET
ARVNNasdaqPharmaceutical Preparations

Arvinas, Inc. · Brief

Next report

4 days

Nov 4 · before openest.Q3 FY26
Earnings

Expected move

Inputs

Implied vs realized

8 reportsHistory
3 of 8≥ implied
avg implied
±14.2%
avg realized
±7.6%
Oct 30 '24±13.3%▲+0.58%×0.04
Feb 11 '25±27.0%▼−6.80%×0.25
May 1 '25±10.6%▼−24.84%×2.35
Aug 6 '25±9.6%▼−15.51%×1.61
Nov 5 '25±13.3%▲+0.31%×0.02
Q1 FY26±22.1%▲+0.57%×0.03
May 12 '26±8.5%▼−0.93%×0.11
Q2 FY26±9.0%▲+11.66%×1.30
quarterimplied−30%0+30%realized×
Q2 FY26±9.0%▲+11.66%×1.30
May '26±8.5%▼−0.93%×0.11
Q1 FY26±22.1%▲+0.57%×0.03
Nov '25±13.3%▲+0.31%×0.02
Aug '25±9.6%▼−15.51%×1.61
May '25±10.6%▼−24.84%×2.35
2 older reports
Feb '25±27.0%▼−6.80%×0.25
Oct '24±13.3%▲+0.58%×0.04
Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Bull & bear

Nov 4 report · est.

Bull2 of 3

4disclosed supplier and customer ties in SEC filingsSEC filings
+11.62%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 3

5 of 8recent reports where the move came in under the options implied rangeEarnings history
7 of 24of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26
AI captions · Sep 28 '26once per report · top 2 per case

Linked exposure

ARVN report session

Customers 2

PFEPfizer×0.10NVSNovartis Pharma×0.09
× = co-movement · max 501dSource: SEC filings · market data

Latest changes

30 daysAll changes
Oct 21impliedImplied move: ±28.1% into Nov 4 earnings (Oct 21 close).Source

Your note

privateThesis 0 · Decisions 0 · Observations 0

No thesis.